Records containing: Polycystic Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-23Polycystic Liver Disease Registry (UK)
-
CLINICAL_TRIALS study record update · 2025-12-11A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Symptomatic Polycystic Liver Disease
-
CLINICAL_TRIALS study record update · 2024-09-19Development and Assessment of the Psychometric Properties of a Polycystic Liver Disease-specific Patient Reported Outcomes Questionnaire (PLD-Q).
-
CLINICAL_TRIALS study record update · 2023-04-05Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts (ATLAS): a Randomized Clinical Trial.
-
CLINICAL_TRIALS study record update · 2022-11-04A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-01-31The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2021-09-23An International, Multicenter, Randomized Controlled Clinical Trial Assessing the Efficacy of Ursodeoxycholic Acid as a Volume Reducing Treatment in Symptomatic Polycystic Liver Disease
-
CLINICAL_TRIALS study record update · 2020-03-02A Randomized, Placebo Controlled Clinical Trial of SOM230 (Pasireotide LAR) In Severe Polycystic Liver Disease
-
CLINICAL_TRIALS study record update · 2019-05-28Automatic Segmentation by a Convolutional Neural Network (Artificial Intelligence - Deep Learning) of Polycystic Livers, as a Model of Multi-lesional Dysmorphic Livers
-
CLINICAL_TRIALS study record update · 2015-06-29Everolimus Added to Long Acting Octreotide as a Volume Reducing Treatment of Polycystic Livers
-
CLINICAL_TRIALS study record update · 2014-07-09The Effect of Lanreotide on Volume of Polycystic Liver and Kidney in Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2014-07-08An Open-label, Phase II Clinical Study to Evaluate the Efficacy and Safety of Lanreotide Autogel 90mg Every 4 Weeks in the Treatment of Symptomatic Polycystic Liver Disease, Including a Dose Escalation at Month 6 to Lanreotide Autogel 120mg for Non Responders
-
CLINICAL_TRIALS study record update · 2013-03-08Single Center, Open-label Randomized Prospective Trial: Effect of Sirolimus on Polycystic Liver Disease
-
CLINICAL_TRIALS study record update · 2012-11-21Pilot Study Of Long-Acting Octreotide (Octreotide LAR® Depot) In The Treatment Of Patients With Severe Polycystic Liver Disease
-
CLINICAL_TRIALS study record update · 2009-02-17Long-Acting Lanreotide as a Volume Reducing Treatment of Polycystic Livers
-
CLINICAL_TRIALS study record update · 2008-11-13Open-Label Extension of the LOCKCYST Trial, LOCKCYST: Long Acting Lnareotide as as Volume Reducing Treatment of Polycystic Livers